May 14, 2013 (Chinavestor) Merck & Co. (NYSE:MRK) and Pfizer (NYSE:PFE) were hand in hand up until yesterday from a technical point of view. We noted that both pharmaceuticals were on top of the oversold chart as a testimony that defensive stocks are disadvantaged when market sentiment is bullish. We also highlighted yesterday that " But this might come handy at a time when the market consolidates. Defensive stocks are always smart addition to aggressive portfolios. This might be the time to do it..." (Pharma stocks remain defensive).